Matches in Nanopublications for { ?s ?p "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP400254.RAohDQL92QvI8NtMfynpdbbDuexh24ifx5Ccnk0PfdKEo130_assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400254.RAohDQL92QvI8NtMfynpdbbDuexh24ifx5Ccnk0PfdKEo130_provenance.
- NP207981.RAEJFGI9HivtQoFGcAUCP9dIA0QnGVRKT5qcp9d3y1Zvc130_assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207981.RAEJFGI9HivtQoFGcAUCP9dIA0QnGVRKT5qcp9d3y1Zvc130_provenance.
- NP427313.RAMOhvrKmAMJVAH0Ap_6GeCwTlQMIBV_XpLsLbbcRr2rg130_assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427313.RAMOhvrKmAMJVAH0Ap_6GeCwTlQMIBV_XpLsLbbcRr2rg130_provenance.
- assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP412342.RAT_711FZX3CQrvX_WTjqlWv8AH_AeCmOdmC2WsJzNEys130_assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412342.RAT_711FZX3CQrvX_WTjqlWv8AH_AeCmOdmC2WsJzNEys130_provenance.
- assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP906916.RAbOCocsLZQI4p04Mf3rjDx83aVE3cJfUhUNn3x8nr0g8130_assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906916.RAbOCocsLZQI4p04Mf3rjDx83aVE3cJfUhUNn3x8nr0g8130_provenance.
- NP906917.RADYX9Chw35PpCanXqfneMct7dSmf3pHNLIQacZDQ3nBs130_assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906917.RADYX9Chw35PpCanXqfneMct7dSmf3pHNLIQacZDQ3nBs130_provenance.
- NP906914.RA_fZ7y4bLIuU83ijbFvuavkVYelSeEBxsklN5VRjKGQE130_assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906914.RA_fZ7y4bLIuU83ijbFvuavkVYelSeEBxsklN5VRjKGQE130_provenance.
- NP906915.RA-j7zjnielMBVXdJk8tWZxNitiBUSq0GVeYbYkn8hsy0130_assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906915.RA-j7zjnielMBVXdJk8tWZxNitiBUSq0GVeYbYkn8hsy0130_provenance.
- NP906919.RA3HZyrv3ZrVl_fhi01D5dMMCAOKz5Vw6rCP6tJ3FywPM130_assertion description "[NVP-BEZ235 is a novel dual inhibitor of PI3K and mTOR; however, its effect on HCC has not been documented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906919.RA3HZyrv3ZrVl_fhi01D5dMMCAOKz5Vw6rCP6tJ3FywPM130_provenance.